Clinical Trials Browser

Phase 1/2 × Terminated × napabucasin × Clear all

NCT02851004 2021-09-05

Special Combination of BBI608 and Pembrolizumab

Phase 1/2 Terminated

Gastrointestinal

Colorectal Neoplasms